Blood Screening for Influenza

Influenza viruses, including highly pathogenic avian influenza virus (H5N1), could threaten blood safety. We analyzed 10,272 blood donor samples with a minipool nucleic acid amplication technique. Analytical sensitivity of the method was 804 geq/mL and 444 geq/mL for generic influenza primers and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hourfar, Michael Kai, Themann, Anna, Eickmann, Markus, Puthavathana, Pilaipan, Laue, Thomas, Seifried, Erhard, Schmidt, Michael
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2007
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878216/
https://www.ncbi.nlm.nih.gov/pubmed/18214186
http://dx.doi.org/10.3201/eid1307.060861
_version_ 1782181838634090496
author Hourfar, Michael Kai
Themann, Anna
Eickmann, Markus
Puthavathana, Pilaipan
Laue, Thomas
Seifried, Erhard
Schmidt, Michael
author_facet Hourfar, Michael Kai
Themann, Anna
Eickmann, Markus
Puthavathana, Pilaipan
Laue, Thomas
Seifried, Erhard
Schmidt, Michael
author_sort Hourfar, Michael Kai
collection PubMed
description Influenza viruses, including highly pathogenic avian influenza virus (H5N1), could threaten blood safety. We analyzed 10,272 blood donor samples with a minipool nucleic acid amplication technique. Analytical sensitivity of the method was 804 geq/mL and 444 geq/mL for generic influenza primers and influenza (H5N1) subtype–specific primers. This study demonstrates that such screening for influenza viruses is feasible.
format Text
id pubmed-2878216
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-28782162010-06-03 Blood Screening for Influenza Hourfar, Michael Kai Themann, Anna Eickmann, Markus Puthavathana, Pilaipan Laue, Thomas Seifried, Erhard Schmidt, Michael Emerg Infect Dis Dispatch Influenza viruses, including highly pathogenic avian influenza virus (H5N1), could threaten blood safety. We analyzed 10,272 blood donor samples with a minipool nucleic acid amplication technique. Analytical sensitivity of the method was 804 geq/mL and 444 geq/mL for generic influenza primers and influenza (H5N1) subtype–specific primers. This study demonstrates that such screening for influenza viruses is feasible. Centers for Disease Control and Prevention 2007-07 /pmc/articles/PMC2878216/ /pubmed/18214186 http://dx.doi.org/10.3201/eid1307.060861 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Hourfar, Michael Kai
Themann, Anna
Eickmann, Markus
Puthavathana, Pilaipan
Laue, Thomas
Seifried, Erhard
Schmidt, Michael
Blood Screening for Influenza
title Blood Screening for Influenza
title_full Blood Screening for Influenza
title_fullStr Blood Screening for Influenza
title_full_unstemmed Blood Screening for Influenza
title_short Blood Screening for Influenza
title_sort blood screening for influenza
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878216/
https://www.ncbi.nlm.nih.gov/pubmed/18214186
http://dx.doi.org/10.3201/eid1307.060861
work_keys_str_mv AT hourfarmichaelkai bloodscreeningforinfluenza
AT themannanna bloodscreeningforinfluenza
AT eickmannmarkus bloodscreeningforinfluenza
AT puthavathanapilaipan bloodscreeningforinfluenza
AT lauethomas bloodscreeningforinfluenza
AT seifriederhard bloodscreeningforinfluenza
AT schmidtmichael bloodscreeningforinfluenza

Ejemplares similares